Zobrazeno 1 - 10
of 698
pro vyhledávání: '"E Peruzzi"'
Publikováno v:
European Journal of Histochemistry, Vol 47, Iss 1 (2009)
Morphochemical age-related features in the hermaphrodite Caenorhabditis elegans are reported. The study of worms of different ages shows a gradual decline in response to the various histochemical reactions and a disorganization of the components of t
Externí odkaz:
https://doaj.org/article/aa1403fdf7e6425fa7bb36b59a74ec00
Autor:
A. Bignucolo, E. De Mattia, R. Roncato, E. Peruzzi, L. Scarabel, M. D’Andrea, F. Sartor, G. Toffoli, E. Cecchin
Publikováno v:
Frontiers in Pharmacology, Vol 14 (2023)
Background: Awareness about the importance of implementing DPYD pharmacogenetics in clinical practice to prevent severe side effects related to the use of fluoropyrimidines has been raised over the years. Since 2012 at the National Cancer Institute,
Externí odkaz:
https://doaj.org/article/700446d8a4a048119e84e0552ffa9d97
Publikováno v:
The Journal of Agricultural Science. :1-16
Meteorological extremes such as heatwaves and water limitations during the ripening season could negatively impact vine ecophysiology and berry metabolism resulting in lower yield per vine. This project aimed to compare two different soil managements
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
M Iacoviello, G Di Gesaro, F Sarullo, D Miani, M Driussi, M Correale, C Bilato, A Passantino, E Carluccio, A Villani, L Degli Esposti, C D’Agostino, E Peruzzi, S Poli, A Di Lenarda
Publikováno v:
European Heart Journal Supplements. 25:D175-D176
Aims The current European Society of Cardiology guidelines provide clear indication for the treatment of acute and chronic heart failure (HF).Nevertheless,there is the constant need of real–world evidence concerning the effectiveness,adherence and
Autor:
I. Nogués, V. Mazzurco Miritana, L. Passatore, M. Zacchini, E. Peruzzi, S. Carloni, F. Pietrini, R. Marabottini, T. Chiti, L. Massaccesi, S. Marinari
Publikováno v:
Geoderma Regional. 33:e00634
Autor:
A Di Lenarda, G Di Gesaro, F Sarullo, D Miani, M Driussi, M Correale, C Bilato, A Passantino, E Carluccio, A Villani, L Degli Esposti, C D‘Agostino, E Peruzzi, S Monopoli, M Iacoviello
Publikováno v:
European Heart Journal Supplements. 25:D134-D134
Background Sacubitril/valsartan reduced heart failure (HF)–related hospitalizations and cardiovascular mortality in PARADIGM–HF and has become a foundational treatment for HF with reduced ejection fraction (HFrEF). However, data of its routine re
Publikováno v:
European Heart Journal Supplements. 24
Background Lipid lowering treatment (LLT) and LDL–C target across CV risk categories might prompt consideration on further lower LDL–C levels advocated by last EAS/ESC guidelines. Aim The aim of the study was to provide current prevalence, clinic
Publikováno v:
European Heart Journal Supplements. 24
Aims The aim of the study was to provide real–world data on low–density lipoprotein cholesterol (LDL–C) goal achievement at the time of current 2019 ESC/EAS Guidelines, treatment patterns and patient adherence to lowering lipid treatment (LLT).